Zaviralec testosteron-5-alfa reduktaze (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zaviralec testosteron-5-alfa reduktaze" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

4^th place

8^th place

low place

1,124^th place

low place

607^th place

1biomedcentral.com

2,747^th place

2,635^th place

2^nd place

5^th place

399^th place

169^th place

biomedcentral.com

Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A (2006). »Finasteride induced depression: a prospective study«. BMC Clinical Pharmacology. 6: 7. doi:10.1186/1472-6904-6-7. PMC 1622749. PMID 17026771.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/o/166F9C9703329732C12579C2003F4B38/$File/s-008996.pdf^{[mrtva povezava]} Povzetek glavnih značilnosti zdravila Propecia, zadnja revizija besedila: 30. 3. 2011.

doi.org

Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A (2006). »Finasteride induced depression: a prospective study«. BMC Clinical Pharmacology. 6: 7. doi:10.1186/1472-6904-6-7. PMC 1622749. PMID 17026771.

drugs.com

»FDA Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change - Increased Risk of Prostate Cancer«. Drugs.com. Pridobljeno 8. junija 2014.

nih.gov

ncbi.nlm.nih.gov

Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A (2006). »Finasteride induced depression: a prospective study«. BMC Clinical Pharmacology. 6: 7. doi:10.1186/1472-6904-6-7. PMC 1622749. PMID 17026771.

pubmed.ncbi.nlm.nih.gov

Rahimi-Ardabili B; Pourandarjani R; Habibollahi P; Mualeki A (2006). »Finasteride induced depression: a prospective study«. BMC Clinical Pharmacology. 6: 7. doi:10.1186/1472-6904-6-7. PMC 1622749. PMID 17026771.

sfd.si

Ilaš J., Obreza A. Zdravila za zdravljenje benigne hiperplazije prostate. Farm vestn 2014; 65: 337–343. http://www.sfd.si/uploads/datoteke/337343.pdf